ZYVERSA THERAPEUTICS INC (ZVSA)
US98987D3008 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -21.33M | -98.30M | -14.12M | -8.08M | -12.68M | |||
| Depreciation Amortization | 9.53K | 10.40K | 10.40K | 10.40K | 10.40K | |||
| Income Taxes - Deferred | -586.39K | -9.48M | -745.10K | N/A | N/A | |||
| Change In Working Capital | -392.03K | 2.60M | 5.66M | -1.02M | 3.11M | |||
| Other non cash items | 13.18M | 96.45M | 4.31M | 4.02M | 4.45M | |||
| OPERATING CASH FLOW | -9.12M | -8.72M | -4.89M | -5.08M | -5.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 5.23M | 1.69M | |||
| Stock Issued/Repurchased | 8.50M | 8.38M | 1.96M | 0.00 | 3.02M | |||
| Other Financing Activity | N/A | -2.42M | -99.10K | 0.00 | -141.70K | |||
| FINANCING CASH FLOW | 7.67M | 5.96M | 1.87M | 5.23M | 4.56M | |||
| CHANGE IN CASH | -1.46M | -2.76M | -3.02M | 153.90K | -549.80K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.12M | -8.72M | -4.89M | -5.08M | -5.11M | |||
| FREE CASH FLOW | -9.12M | -8.72M | -4.89M | -5.08M | -5.11M | |||
All data in USD